Pfizer (NYSE:PFE) is currently dealing with shareholder proposals concerning governance issues such as religious ...

The latest trading day saw Pfizer (PFE) settling at $25.60, representing a -0.43% change from its previous close.

Pfizer offers a 6.7% dividend yield, trading at a low valuation with resilient drug portfolio growth. Realty Income Corp. has ...

Seven of the ten lowest-priced BBB "Safer" dividend stocks meet the dogcatcher ideal. Read more to see the picks.

Representative Julie Johnson (D-Texas) recently sold shares of Pfizer Inc. (NYSE:PFE). In a filing disclosed on March 12th, the Representative disclosed that they had sold between $1,001 and $15,000 ...

Representative Jefferson Shreve (R-Indiana) recently bought shares of Pfizer Inc. (NYSE:PFE). In a filing disclosed on March ...

Four Goldman Sachs stock picks make sense for growth and income investors charting a course for the rest of what could be a ...

Involves transaction of at least 0.5% of the listed shares of a company. Pfizer Ltd share price was down by -1.36% from the previous closing price of ₹4,148.35. Who are peers of Pfizer Ltd?

BioNTech's Q4 revenue beat estimates despite lower COVID-19 vaccine sales. The company advances oncology programs, with key ...

The drug in question, called vepdegestrant, is an oral PROteolysis TArgeting Chimera (PROTAC) ER degrader. The phase 3 study ...

Even though the stock has become cheaper, we're swiping left on Pfizer for now. Here are three reasons why there are better opportunities than PFE and a stock we'd rather own. Founded in 1849, Pfizer ...

The diabetes and weight loss drug market is heating up in 2025, with significant growth signs everywhere. According to a recent study from Research and Markets, industry growth is running at an ...